The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Discontinuing antidepressant treatment in major depression.
Abstract
Maintenance treatments in bipolar disorders and schizophrenia are securely established, and their discontinuation is associated with high but modifiable risk of early relapse. The benefits of long-term antidepressant treatment in major depression and the risks of discontinuing medication at various times after clinical recovery from acute depression are not as well defined. Computerized searching found 27 studies with data on depression risk over time including a total of 3037 depressive patients treated for 5.78 (0-48) months and then followed for 16.6 (5-66) months with antidepressants continued or discontinued. Compared with patients whose antidepressants were discontinued, those with continued treatment showed much lower relapse rates (1.85 vs. 6.24%/month), longer time to 50% relapse (48.0 vs. 14.2 months), and lower 12-month relapse risk (19.5 vs. 44.8%) (all p < 0.001). However, longer prior treatment did not yield lower postdiscontinuation relapse risk, and differences in relapses off versus on antidepressants fell markedly with longer follow-up. Contrary to prediction, gradual discontinuation (dose-tapering or use of long-acting agents) did not yield lower relapse rates. Relapse risk was not associated with diagnostic criteria. More previous illness (particularly three or more prior episodes or a chronic course) was strongly associated with higher relapse risk after discontinuation of antidepressants but had no effect on response to continued treatment; patients with infrequent prior illness showed only minor relapse differences between drug and placebo treatment.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“While Viguera et al. (1998) found that patients with more prior episodes benefited more from antidepressant treatment”
From Predicting relapse after antidepressant withdrawal – a systematic review (2017) · cites this paper as Viguera et al. 1998
In the citing paper
“In addition, discontinuation itself is likely to have an effect on relapse, indicated by the increased risk in the early months following discontinuation, which is independent of length of prior treatment (Viguera et al. 1998).”
From Predicting relapse after antidepressant withdrawal – a systematic review (2017) · cites this paper as Viguera et al. 1998
In the citing paper
“Several meta-analyses (Viguera et al. 1998; Geddes et al. 2003; Kaymaz et al. 2008; Glue et al. 2010; Andrews et al. 2011) have, however, examined it, with none finding a significant effect.”
From Predicting relapse after antidepressant withdrawal – a systematic review (2017) · cites this paper as Viguera et al. 1998
Citations
Cites
Kessler, R. C. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950010008002 · Cited by 12,370
Lifetime Prevalence of Specific Psychiatric Disorders in Three Sites
Robins, L. N. (1984) · Archives of General Psychiatry · doi:10.1001/archpsyc.1984.01790210031005 · Cited by 2,550 · cited 1×
“(2) Slow removal of an antidepressant, or stopping a long-acting agent (such as fluoxetine or a standard monoamine oxidase inhibitor [MAOI]), would be followed by less morbid risk in the ensuing months than would abrupt or rapid discontinuation of long-term treatment with a short-acting antidepressant.”
Cross-national epidemiology of major depression and bipolar disorder
Weissman, M. M. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540040037030 · Cited by 2,302
Three-Year Outcomes for Maintenance Therapies in Recurrent Depression
Frank, E. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810240013002 · Cited by 1,297
(1994) · PharmacoResources · doi:10.1007/bf03289581 · Cited by 974
Hirschfeld, R. M. A. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03540280071036 · Cited by 895
Prien, R. F. (1984) · Archives of General Psychiatry · doi:10.1001/archpsyc.1983.01790220086014 · Cited by 565
Treatment of Depression by Drugs and Psychotherapy
KLERMAN, G. L., DIMASCIO, A., WEISSMAN, M., PRUSOFF, B., & PAYKEL, E. S. (1974) · American Journal of Psychiatry · doi:10.1176/ajp.131.2.186 · Cited by 500
Risk of Recurrence Following Discontinuation of Lithium Treatment in Bipolar Disorder
Suppes, T. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810360046007 · Cited by 392 · cited 2×
“1 (6-60) months yielded a computed time to 50% risk of relapse (-+ SE) of 48.”
Long-term Outcome of Episodes of Major Depression: Clinical and Public Health Significance
Keller, M. B. (1984) · JAMA · doi:10.1001/jama.252.6.788 · Cited by 295
Cited by
Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review
Geddes, J. R., Carney, S. M., Davies, C., Furukawa, T. A., Kupfer, D. J., Frank, E., & Goodwin, G. M. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12599-8 · Cited by 945
Malhi, G. S., Bassett, D., Boyce, P., Bryant, R., Fitzgerald, P. B., Fritz, K., Hopwood, M., Lyndon, B., Mulder, R., Murray, G., et al. (2015) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867415617657 · Cited by 842
“…continuation of antidepressant treatment at the therapeutic dose that was effective during acute treatment for at least 1 year following an initial episode and at least 3 years for recurrent episodes (Bauer, 2007) and episodes which included psychotic features (Viguera et al., 1998) (CBR).”
BackgroundViguera, A. C., Nonacs, R., Cohen, L. S., Tondo, L., Murray, A., & Baldessarini, R. J. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.2.179 · Cited by 488
Self-citationBauer, M., Bschor, T., Pfennig, A., Whybrow, P. C., Angst, J., Versiani, M., Möller, H.-J., WFSBP Task Force on Unipolar Depres, Bauer, M., Bschor, T., et al. (2007) · The World Journal of Biological Psychiatry · doi:10.1080/15622970701227829 · Cited by 477
Davies, J., & Read, J. (2019) · Addictive Behaviors · doi:10.1016/j.addbeh.2018.08.027 · Cited by 387
Metadata
- Authors
- Viguera, A. C., Baldessarini, R. J., & Friedberg, J.
- Affiliations
- Harvard University (US)
- Corresponding author
- Baldessarini, Ross J.
- Venue
- Harvard Review of Psychiatry
- Published
- 1998-03
- Volume
- 5
- Issue
- 6
- Pages
- 293-306
- ISSN
- 1067-3229 (ISSN-L)
- OpenAlex
- W2061813324
- Cited by
- 145
- References
- 47
- Citations by year
- 2026: 2 · 2024: 9 · 2023: 2 · 2022: 3 · 2021: 4 · 2020: 7 · 2019: 5 · 2018: 4 · 2017: 3 · 2016: 3 · 2015: 5 · 2014: 5 · 2013: 5 · 2012: 9
- FWCI
- 3.40
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Harvard Review of Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5k05mh047370-25)
- National Institute of Mental Health (MH47370)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Keywords
- antidepressant discontinuation, major depressive disorder, relapse risk, maintenance therapy, long-term antidepressant treatment, dose tapering, chronic depression, time to relapse
- MeSH terms
- Analysis of Variance, Antidepressive Agents, Depressive Disorder, Humans, Survival Analysis, Statistics, Nonparametric, Secondary Prevention
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Discontinuing antidepressant treatment in major depression. https://app.cochat.ai/papers/10.3109/10673229809003578
- The paper
- Viguera, A. C., Baldessarini, R. J., & Friedberg, J. (1998). Discontinuing antidepressant treatment in major depression. Harvard Review of Psychiatry. https://doi.org/10.3109/10673229809003578
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.